SELLAS Life Sciences (SLS) Preferred Shares Issued (2018)
SELLAS Life Sciences (SLS) reported Preferred Shares Issued of $4.3 million for Q2 2018, down 18.94% quarter-over-quarter from $5.3 million in Q1 2018.
SELLAS Life Sciences (SLS) Preferred Shares Issued (2018) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of Preferred Shares Issued data on file, last reported at $4.3 million in Q2 2018.
- Preferred Shares Issued for Q2 2018 came in at $4.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2019 was $4.3 million (down 18.94% YoY), and the FY2018 annual result was $9.6 million, changed N/A from the prior year.
- Preferred Shares Issued eased to $4.3 million in Q2 2018 per SLS's latest filing, from $5.3 million in the prior quarter.
- Over five years, Preferred Shares Issued peaked at $5.3 million in Q1 2018 and troughed at $4.3 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 4.32 Mn |
| Jun 30, 2018 | 4.32 Mn |
| Mar 31, 2018 | 5.33 Mn |
| Mar 31, 2018 | 5.33 Mn |